Martine A. Rothblatt
CHAIRPERSON & CEO at United Therapeutics Corporation
Sits on 2 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: United Therapeutics Corporation, 3 years.
United Therapeutics Corporation
Director · Chairperson & CEO
Beta Technologies Inc.
Director
Chief executive roles
United Therapeutics Corporation
· CHAIRPERSON & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 24, 2026 | United Therapeutics Corporation | Option exercise | +9,500 | $117.76 | $1,118,720 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −640 | $469.74 | $300,631 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −2,603 | $470.63 | $1,225,045 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −2,160 | $471.77 | $1,019,026 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −580 | $472.73 | $274,184 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −437 | $474.01 | $207,141 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −320 | $475.35 | $152,114 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −280 | $476.51 | $133,424 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −360 | $477.58 | $171,930 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −1,480 | $478.61 | $708,337 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −600 | $479.52 | $287,710 |
| Sep 24, 2026 | United Therapeutics Corporation | Open-market sale | −40 | $480.33 | $19,213 |
| Sep 23, 2026 | United Therapeutics Corporation | Option exercise | +9,500 | $117.76 | $1,118,720 |
| Sep 23, 2026 | United Therapeutics Corporation | Open-market sale | −2,388 | $488.70 | $1,167,007 |
| Sep 23, 2026 | United Therapeutics Corporation | Open-market sale | −2,162 | $489.52 | $1,058,351 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.